8-K - BridgeBio Pharma, Inc. (0001743881) (Filer)
Published . Updated .
Filed: 2026-10-13 AccNo: 0001140361-26-039334 Size: 169 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Directly affected
- BBIO BridgeBio Pharma
Named in this report.
Indirectly affected
- ACHC ACADIA HEALTHCARE COMPANY INC
GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ASND ASCENDIS PHARMA A/S
GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ATYR ATYR PHARMA INC COM NEW
GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- DVA DaVita HealthCare Partners, Inc.
GA selected DVA as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- GEHC GE HEALTHCARE TECHNOLOGIES I
GA selected GEHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- HCA HCA HEALTHCARE INC
GA selected HCA as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
Filed: 2026-10-13 AccNo: 0001140361-26-039334 Size: 169 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
BridgeBio Pharma (BBIO) since this story, compared with the market
Since the first closing price after “8-K - BridgeBio Pharma, Inc. (0001743881) (Filer),” BridgeBio Pharma (BBIO) is +4.57%. The S&P 500 fund (SPY) is -0.40% over the same days, a +4.97% difference versus the market.
| Company | When | Move | Status |
|---|---|---|---|
| Acadia Healthcare (ACHC) | that day | +0.50% | final price |
| Acadia Healthcare (ACHC) | the next day | +5.29% | final price |
| Acadia Healthcare (ACHC) | two days later | +3.19% | final price |
| Acadia Healthcare (ACHC) | three days later | -0.33% | final price |
| Acadia Healthcare (ACHC) | three days earlier | -5.32% | final price |
| Acadia Healthcare (ACHC) | five days earlier | -3.46% | final price |
| Ascendis Pharma A/S (ASND) | that day | -1.62% | final price |
| Ascendis Pharma A/S (ASND) | the next day | +0.04% | final price |
| Ascendis Pharma A/S (ASND) | two days later | -0.14% | final price |
| Ascendis Pharma A/S (ASND) | three days later | -0.76% | final price |
| Ascendis Pharma A/S (ASND) | three days earlier | -1.88% | final price |
| Ascendis Pharma A/S (ASND) | five days earlier | -0.35% | final price |
| aTYR PHARMA (ATYR) | that day | -7.79% | final price |
| aTYR PHARMA (ATYR) | the next day | -16.23% | final price |
| aTYR PHARMA (ATYR) | two days later | -14.52% | final price |
| aTYR PHARMA (ATYR) | three days later | -18.17% | final price |
| aTYR PHARMA (ATYR) | three days earlier | +18.40% | final price |
| aTYR PHARMA (ATYR) | five days earlier | +30.15% | final price |
| BridgeBio Pharma (BBIO) | that day | -3.73% | final price |
| BridgeBio Pharma (BBIO) | the next day | -1.23% | final price |
| BridgeBio Pharma (BBIO) | two days later | +2.10% | final price |
| BridgeBio Pharma (BBIO) | three days later | +0.97% | final price |
| BridgeBio Pharma (BBIO) | three days earlier | -1.08% | final price |
| BridgeBio Pharma (BBIO) | five days earlier | +1.84% | final price |
| Davita (DVA) | that day | +0.34% | final price |
| Davita (DVA) | the next day | -0.54% | final price |
| Davita (DVA) | two days later | +4.08% | final price |
| Davita (DVA) | three days later | +2.99% | final price |
| Davita (DVA) | three days earlier | -2.48% | final price |
| Davita (DVA) | five days earlier | -0.74% | final price |
Who reported a BridgeBio Pharma (BBIO) trade near this story
- Gilbert Cisneros sell BridgeBio Pharma (BBIO) ($1,001 - $15,000). That is 14 days before publication, inside 30 days. The filing is listed beside the story “8-K - BridgeBio Pharma, Inc. (0001743881) (Filer).”
- Rohit Khanna buy GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 32 days before publication, inside 60 days. The filing is listed beside the story “8-K - BridgeBio Pharma, Inc. (0001743881) (Filer).”
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - BridgeBio Pharma, Inc. (0001743881) (Filer)”
Companies tied to this story
- BBIO BridgeBio Pharma
In “8-K - BridgeBio Pharma, Inc. (0001743881) (Filer),” BridgeBio Pharma (BBIO) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> BBIO
- ACHC Acadia Healthcare
For “8-K - BridgeBio Pharma, Inc. (0001743881) (Filer),” Acadia Healthcare (ACHC) is linked, with no stored direction, medium confidence. Reason on file: GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ASND Ascendis Pharma A/S
In “8-K - BridgeBio Pharma, Inc. (0001743881) (Filer),” Ascendis Pharma A/S (ASND) is linked, with no stored direction, medium confidence. Reason on file: GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ATYR aTYR PHARMA
aTYR PHARMA (ATYR) is linked, with no stored direction, medium confidence in the 13 Oct 2026 story “8-K - BridgeBio Pharma, Inc. (0001743881) (Filer).” Reason on file: GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- DVA Davita
Davita (DVA) is linked, with no stored direction, medium confidence in the 13 Oct 2026 story “8-K - BridgeBio Pharma, Inc. (0001743881) (Filer).” Reason on file: GA selected DVA as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- GEHC GE HealthCare Technologies
For “8-K - BridgeBio Pharma, Inc. (0001743881) (Filer),” GE HealthCare Technologies (GEHC) is linked, with no stored direction, medium confidence. Reason on file: GA selected GEHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- HCA HCA Healthcare
In “8-K - BridgeBio Pharma, Inc. (0001743881) (Filer),” HCA Healthcare (HCA) is linked, with no stored direction, medium confidence. Reason on file: GA selected HCA as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
How “8-K - BridgeBio Pharma, Inc. (0001743881) (Filer)” reaches BridgeBio Pharma (BBIO)
BridgeBio Pharma (BBIO) is the company in “8-K - BridgeBio Pharma, Inc. (0001743881) (Filer),” the 13 Oct 2026 this story story.
What ties BridgeBio Pharma (BBIO) to the headline is this: SEC 8-K filing -> direct issuer disclosure -> BBIO
Also listed, Acadia Healthcare (ACHC): GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Dates in the story, and the BridgeBio Pharma (BBIO) price range
ACHC traded between 26.75 and 32.03 across 20 sessions. The latest close on file is 30.20. ASND traded between 219.69 and 240.84 across 20 sessions. The latest close on file is 229.99. BBIO traded between 62.95 and 69.80 across 20 sessions. The latest close on file is 67.94.
A simple score for BridgeBio Pharma (BBIO)
46 out of 100
“8-K - BridgeBio Pharma, Inc. (0001743881) (Filer)” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.